This week, five health care provider stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
Cross Country Healthcare, Inc. (CCRN) is bumping up its rating from a C (“hold”) to a B (“buy”) this week. Cross Country Healthcare provides healthcare staffing and outsourcing services to the healthcare market. In Portfolio Grader’s specific subcategories of Earnings Momentum, Earnings Surprise and Sales Growth, CCRN also gets A’s. For more information, get Portfolio Grader’s complete analysis of CCRN stock.
This week, Triple-S Management Corporation Class B (GTS) pushes up from an A to a C rating. Triple-S Management is an independent licensee of the Blue Cross Blue Shield Association. For more information, get Portfolio Grader’s complete analysis of GTS stock.
Fresenius Medical Care AG & Co. KGaA Sponsored ADR (FMS) is seeing ratings go up from a C last week to a B this week. Fresenius Medical Care offers kidney dialysis services and manufactures and distributes equipment and products used in the treatment of dialysis patients. For more information, get Portfolio Grader’s complete analysis of FMS stock.
This week, Bio-Reference Laboratories, Inc. (BRLI) is making solid headway. The company’s rating improves to an A (“strong buy”) from last week’s B (“buy”) rating. Bio-Reference provides laboratory testing services, primarily to customers in the greater New York metropolitan area. For more information, get Portfolio Grader’s complete analysis of BRLI stock.
The rating of DaVita HealthCare Partners Inc. (DVA) moves up this week, rising from a C to a B. DaVita operates kidney dialysis centers in the United States. For more information, get Portfolio Grader’s complete analysis of DVA stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
